Xencor, Inc Employee-related Liabilities, Current
Xencor, Inc (XNCR) had Employee-related Liabilities, Current of $13.76 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Employee-related Liabilities, Current $13.76M.
- 2026-03-31: Employee-related Liabilities, Current $11.69M.
- 2025-12-31: Employee-related Liabilities, Current $20.21M.
- 2025-09-30: Employee-related Liabilities, Current $16.17M.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $13.76M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $11.69M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $20.21M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $16.17M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $12.52M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $7.95M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $14.85M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |